Literature DB >> 17363573

Inhibitor of growth 4 suppresses cell spreading and cell migration by interacting with a novel binding partner, liprin alpha1.

Jiang-Cheng Shen1, Motoko Unoki, Damien Ythier, Alain Duperray, Lyuba Varticovski, Kensuke Kumamoto, Remy Pedeux, Curtis C Harris.   

Abstract

Inhibitor of growth 4 (ING4) is a candidate tumor suppressor that plays a major role in gene regulation, cell cycle control, apoptosis, and angiogenesis. ING4 expression is down-regulated in glioblastoma cells and head and neck squamous cell carcinoma. Here, we identified liprin alpha1/PPFIA1, a cytoplasmic protein necessary for focal adhesion formation and axon guidance, as a novel interacting protein with ING4. ING4 and liprin alpha1 colocalized at lamellipodia in the vicinity of vinculin. Overexpressed ING4 suppressed cell spreading and cell migration. In contrast, overexpressed liprin alpha1 enhanced cell spreading and cell migration. Knockdown of endogenous ING4 with RNA interference induced cell motility, whereas knockdown of endogenous liprin alpha1 suppressed cell motility. ING4 also suppressed cell motility that was enhanced by liprin alpha1. However, ING4 did not further suppress cell motility when liprin alpha1 was suppressed with RNA interference, suggesting a functional and mechanistic interdependence between these proteins. In addition to its nuclear functions, cytoplasmic ING4 interacts with liprin alpha1 to regulate cell migration and, with its known antiangiogenic function, may prevent invasion and metastasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17363573      PMCID: PMC2569966          DOI: 10.1158/0008-5472.CAN-06-3870

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  26 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 2.  Cell migration: integrating signals from front to back.

Authors:  Anne J Ridley; Martin A Schwartz; Keith Burridge; Richard A Firtel; Mark H Ginsberg; Gary Borisy; J Thomas Parsons; Alan Rick Horwitz
Journal:  Science       Date:  2003-12-05       Impact factor: 47.728

3.  DNA damage-inducible gene p33ING2 negatively regulates cell proliferation through acetylation of p53.

Authors:  M Nagashima; M Shiseki; K Miura; K Hagiwara; S P Linke; R Pedeux; X W Wang; J Yokota; K Riabowol; C C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

4.  Impaired mammary gland development and function in mice lacking LAR receptor-like tyrosine phosphatase activity.

Authors:  R Q Schaapveld; J T Schepens; G W Robinson; J Attema; F T Oerlemans; J A Fransen; M Streuli; B Wieringa; L Hennighausen; W J Hendriks
Journal:  Dev Biol       Date:  1997-08-01       Impact factor: 3.582

5.  Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation.

Authors:  I Garkavtsev; A Kazarov; A Gudkov; K Riabowol
Journal:  Nat Genet       Date:  1996-12       Impact factor: 38.330

6.  p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity.

Authors:  Masayuki Shiseki; Makoto Nagashima; Remy M Pedeux; Mariko Kitahama-Shiseki; Koh Miura; Shu Okamura; Hitoshi Onogi; Yuichiro Higashimoto; Ettore Appella; Jun Yokota; Curtis C Harris
Journal:  Cancer Res       Date:  2003-05-15       Impact factor: 12.701

7.  A novel PHD-finger motif protein, p47ING3, modulates p53-mediated transcription, cell cycle control, and apoptosis.

Authors:  Makoto Nagashima; Masayuki Shiseki; Remy M Pedeux; Shu Okamura; Mariko Kitahama-Shiseki; Koh Miura; Jun Yokota; Curtis C Harris
Journal:  Oncogene       Date:  2003-01-23       Impact factor: 9.867

8.  The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis.

Authors:  Igor Garkavtsev; Sergey V Kozin; Olga Chernova; Lei Xu; Frank Winkler; Edward Brown; Gene H Barnett; Rakesh K Jain
Journal:  Nature       Date:  2004-03-18       Impact factor: 49.962

9.  GIT1 functions in a motile, multi-molecular signaling complex that regulates protrusive activity and cell migration.

Authors:  Ri-ichiroh Manabe; Mykola Kovalenko; Donna J Webb; Alan Rick Horwitz
Journal:  J Cell Sci       Date:  2002-04-01       Impact factor: 5.285

10.  The LAR transmembrane protein tyrosine phosphatase and a coiled-coil LAR-interacting protein co-localize at focal adhesions.

Authors:  C Serra-Pagès; N L Kedersha; L Fazikas; Q Medley; A Debant; M Streuli
Journal:  EMBO J       Date:  1995-06-15       Impact factor: 11.598

View more
  47 in total

Review 1.  The ING family tumor suppressors: from structure to function.

Authors:  Almass-Houd Aguissa-Touré; Ronald P C Wong; Gang Li
Journal:  Cell Mol Life Sci       Date:  2010-08-29       Impact factor: 9.261

2.  Rapamycin-upregulated miR-29b promotes mTORC1-hyperactive cell growth in TSC2-deficient cells by downregulating tumor suppressor retinoic acid receptor β (RARβ).

Authors:  Heng-Jia Liu; Hilaire C Lam; Christian V Baglini; Julie Nijmeh; Alischer A Cottrill; Stephen Y Chan; Elizabeth P Henske
Journal:  Oncogene       Date:  2019-08-16       Impact factor: 9.867

3.  Heterogeneity of 11q13 region rearrangements in laryngeal squamous cell carcinoma analyzed by microarray platforms and fluorescence in situ hybridization.

Authors:  Małgorzata Jarmuz-Szymczak; Kinga Pelinska; Magdalena Kostrzewska-Poczekaj; Ewa Bembnista; Maciej Giefing; Damian Brauze; Marcin Szaumkessel; Andrzej Marszalek; Joanna Janiszewska; Katarzyna Kiwerska; Anna Bartochowska; Reidar Grenman; Witold Szyfter; Krzysztof Szyfter
Journal:  Mol Biol Rep       Date:  2013-05-08       Impact factor: 2.316

4.  Deletion of the inhibitor of growth 4 (ING4) tumor suppressor gene is prevalent in human epidermal growth factor 2 (HER2)-positive breast cancer.

Authors:  Coya Tapia; Inti Zlobec; Sandra Schneider; Ergin Kilic; Uwe Güth; Lukas Bubendorf; Suwon Kim
Journal:  Hum Pathol       Date:  2011-02-11       Impact factor: 3.466

5.  ING4 is negatively correlated with microvessel density in colon cancer.

Authors:  Chun Lou; Shixiong Jiang; Xinggang Guo; Xin-shu Dong
Journal:  Tumour Biol       Date:  2012-09-28

6.  miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas.

Authors:  Shouwei Li; Ailiang Zeng; Qi Hu; Wei Yan; Yanwei Liu; Yongping You
Journal:  Neuro Oncol       Date:  2016-07-28       Impact factor: 12.300

Review 7.  ING proteins as potential anticancer drug targets.

Authors:  M Unoki; K Kumamoto; C C Harris
Journal:  Curr Drug Targets       Date:  2009-05       Impact factor: 3.465

8.  ING4 mediates crosstalk between histone H3 K4 trimethylation and H3 acetylation to attenuate cellular transformation.

Authors:  Tiffany Hung; Olivier Binda; Karen S Champagne; Alex J Kuo; Kyle Johnson; Howard Y Chang; Matthew D Simon; Tatiana G Kutateladze; Or Gozani
Journal:  Mol Cell       Date:  2009-01-30       Impact factor: 17.970

9.  Sequence features involved in the mechanism of 3' splice junction wobbling.

Authors:  Kuo-Wang Tsai; Wen-Ching Chan; Chun-Nan Hsu; Wen-Chang Lin
Journal:  BMC Mol Biol       Date:  2010-05-07       Impact factor: 2.946

Review 10.  The ING gene family in the regulation of cell growth and tumorigenesis.

Authors:  Andrew H Coles; Stephen N Jones
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.